[1] Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system:a summary[J]. Acta Neuropathologica, 2016, 131:803-820.
[2] Kamoshima Y, Sawamura Y. Update on current standard treatments in central nervous system germ cell tumors[J]. Curr Opin Neurol, 2010, 2:571-575.
[3] Lai IC, Wong TT, Shiau CY, Hu YW, Ho DM, Chang KP, Guo WY, Chang FC, Liang ML, Lee YY, Chen HH, Yen SH, Chen YW. Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors:single institute experience[J]. Childs Nerv Syst, 2015, 31:683-691.
[4] Denyer S, Bhimani AD, Patil SN, Mudreac A, Behbahani M, Mehta AI. Treatment and survival of primary intracranial germ cell tumors:a population-based study using SEER database[J]. J Cancer Res Clin Oncol, 2019, 146:671-685.
[5] Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, Seto T. Primary intracranial germ cell tumors:a clinical analysis of 153 histologically verified cases[J]. J Neurosurg, 1997, 86:446-455.
[6] Mufti ST, Jamal A. Primary intracranial germ cell tumors[J]. Asian J Neurosurg, 2012, 7:197-202.
[7] Fetcko K, Dey M. Primary central nervous system germ cell tumors:a review and update[J]. Med Res Arch, 2018, 6:pii1719.
[8] Bowzyk Al-Naeeb A, Murray M, Horan G, Harris F, Kortmann RD, Nicholson J, Ajithkumar T. Current management of intracranial germ cell tumours[J]. Clin Oncol (R Coll Radiol), 2018, 30:204-214.
[9] Cardellicchio S, Farina S, Buccoliero AM, Agresti B, Genitori L, de Martino M, Fangusaro J, Sardi I. Successful treatment of metastatic beta HCG-secreting germ cell tumor occurring 3 years after total resection of a pineal mature teratoma[J]. Eur J Pediatr, 2014, 173:1011-1015.
[10] Yang QY, Guo CC, Deng ML, Wang J, Wang J, Lin FH, Zhang J, Jiang XB, Mou YG, Chen ZP. Treatment of primary intracranial germ cell tumors:single center experience with 42 clinically diagnosed cases[J]. Oncotarget, 2016, 7:60665-60675.
[11] Murray MJ, Bailey S, Heinemann K, Mann J, Göbel UK, Saran F, Hale JP, Calaminus G, Nicholson JC. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy[J]. Int J Cancer, 2017, 141:621-635.
[12] Sun XF, Zhang F, Zhen ZJ, Yang QY, Xia YF, Wu SX, Zhu J, Lu SY, Wang J, Sun FF, Cai RQ, Chen Y, Li PF. The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors[J]. Chin J Cancer, 2014, 33:395-401.
[13] Bromberg JE, Baumert BG, de Vos F, Gijtenbeek JM, Kurt E, Westermann AM, Wesseling P. Primary intracranial germ-cell tumors in adults:a practical review[J]. J Neurooncol, 2013, 113:175-183.
[14] Iczkowski KA, Butler SL, Shanks JH, Hossain D, Schall A, Meiers I, Zhou M, Torkko KC, Kim SJ, MacLennan GT. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors[J]. Hum Pathol, 2008, 39:275-281.
[15] Nagasawa DT, Lagman C, Sun M, Yew A, Chung LK, Lee SJ, Bui TT, Ooi YC, Robison RA, Zada G, Yang I. Pineal germ cell tumors:two cases with review of histopathologies and biomarkers[J]. J Clin Neurosci, 2017, 38:23-31.
[16] Sato K, Takeuchi H, Kubota T. Pathology of intracranial germ cell tumors[J]. Prog Neurol Surg, 2009, 23:59-75.
[17] Song YY. Progress in diagnosis and treatment of intracranial germ cell tumors in children[J]. Guo Ji Er Ke Xue Za Zhi, 2019, 46:589-593.[宋媛媛. 儿童颅内生殖细胞肿瘤诊治进展[J]. 国际儿科学杂志, 2019, 46:589-593.]
[18] Takeuchi J, Hirai O, Konishi T, Gi S, Watanabe H, Handa H, Ohta T, Nishimura S. Value of blood AFP and HCG levels in the diagnosis of intracranial germ cell tumors[J]. Neurol Med Chir (Tokyo), 1980, 20:1197-1202.
[19] Ho DM, Liu HC. Primary intracranial germ cell tumor:pathologic study of 51 patients[J]. Cancer, 1992, 70:1577-1584.
[20] Shinoda J, Miwa Y, Sakai N, Yamada H, Shima H, Kato K, Takahashi M, Shimokawa K. Immunohistochemical study of placental alkaline phosphatase in primary intracranial germ-cell tumors[J]. J Neurosurg, 1985, 63:733-739.
[21] Gao Y, Jiang J, Liu Q. Extragonadal malignant germ cell tumors:a clinicopathological and immunohistochemical analysis of 48 cases at a single Chinese institution[J]. Int J Clin Exp Pathol, 2015, 8:5650-5607.
[22] Teng LH, Lu DH, Xu QZ, Fu YJ, Yang H. Expression and differential diagnoisi of OCT4, CD117 and CD30 in germ cell tumors[J]. Zhonghua Bing Li Xue Za Zhi, 2005, 34:18-22.[滕梁红, 卢德宏, 徐庆中, 付永娟, 杨虹. OCT4、CD117、CD30在生殖细胞肿瘤中的表达及鉴别诊断意义[J]. 中华病理学杂志, 2005, 34:18-22.]
[23] Watanabe A, Horikoshi T, Naganuma H, Satoh E, Nukui H. Intramedullary spinal cord germinoma expresses the protooncogene c-kit[J]. Acta Neurochirurgica, 2005, 147:303-308.
[24] Sakuma Y, Sakurai S, Oguni S, Satoh M, Hironaka M, Saito K. c-kit gene mutations in intracranial germinomas[J]. Cancer Sci, 2004, 95:716-720.
[25] Takeshima H, Kaji M, Uchida H, Hirano H, Kuratsu J. Expression and distribution of c-kit receptor and its ligand in human CNS germ cell tumors:a useful histological marker for the diagnosis of germinoma[J]. Brain Tumor Pathol, 2004, 21:13-16.
[26] Miyanohara O, Takeshima H, Kaji M, Hirano H, Sawamura Y, Kochi M, Kuratsu J. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors[J]. J Neurosurg, 2002, 97:177-183.
[27] Bu JS, Li BY, Qin CL, Miao S. Research advances of SALL4 in disease[J]. Zhong Wai Yi Xue Yan Jiu, 2011, 9:157-159.[卜建设, 李宝艳, 秦成路, 廖莳. SALL4在疾病中的研究进展[J]. 中外医学研究, 2011, 9:157-159.]
[28] Mei K, Liu A, Allan RW, Wang P, Lane Z, Abel TW, Wei L, Cheng H, Guo S, Peng Y, Rakheja D, Wang M, Ma J, Rodriguez MM, Li J, Cao D. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system:a study of 77 cases[J]. Mod Pathol, 2009, 22:1628-1636.
[29] Inoue HK, Naganuma H, Ono N. Pathobiology of intracranial germ-cell tumors:immunochemical, immunohistochemical, and electron microscopic investigations[J]. J Neurooncol, 1987, 5:105-115.
[30] Nakagawa Y, Perentes E, Ross GW, Ross AN, Rubinstein LJ. Immunohistochemical differences between intracranial germinomas and their gonadal equivalents:an immunoperoxidase study of germ cell tumors with epithelial membrane antigen, cytokeratin, and vimentin[J]. J Pathol, 1988, 156:67-72.
[31] Huang X, Zhang R, Mao Y, Zhou LF, Zhang C. Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors[J]. World J Pediatr, 2016, 12:275-282.
[32] Terashima K, Yu A, Chow WY, Hsu WC, Chen P, Wong S, Hung YS, Suzuki T, Nishikawa R, Matsutani M, Nakamura H, Ng HK, Allen JC, Aldape KD, Su JM, Adesina AM, Leung HC, Man TK, Lau CC. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors[J]. Pediatr Blood Cancer, 2014, 61:593-600.
[33] Kim D, Lee DH, Choi J, Shim KW, Kim SH. Validation of tumor markers in central nervous system germ cell tumors by real-time reverse transcriptase polymerase chain reaction using formalin-fixed paraffin-embedded tissues[J]. Mol Med Rep, 2013, 7:337-341.
[34] Nishikawa R, Matsutani M. Immunohistochemical analysis of p53 and p21(WAF1/Cip1) expression in primary intracranial germ cell tumors[J]. Neurosurg Focus, 1998, 5:E2.
[35] Kim SK, Cho BK, Paek SH, Hong SJ, Kim HS, Hong SY, Choe G, Chi JG, Nam DH, Wang KC. The detection of p53 gene mutation using a microdissection technique in primary intracranial germ cell tumors[J]. Int J Oncol, 2001, 18:111-116.
[36] Iwato M, Tachibana O, Tohma Y, Nitta H, Hayashi Y, Yamashita J. Molecular analysis for p53 and mdm2 in intracranial germ cell tumors[J]. Acta Neuropathol, 2000, 99:21-25.
[37] Cao D, Liu A, Wang F, Allan RW, Mei K, Peng Y, Du J, Guo S, Abel TW, Lane Z, Ma J, Rodriguez M, Akhi S, Dehiya N, Li J. RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors:an immunohistochemical study of 131 cases[J]. Mod Pathol, 2011, 24:288-296.
[38] Li YF, Zhang X, Wang XF, Weng MJ, Wang TZ. The role and molecular mechanism of RNA-binding protein LIN28 in malignant tumors[J]. Shi Yong Zhong Liu Xue Za Zhi, 2019, 33:456-460.[李亚飞, 张霄, 王雪飞, 翁明娇, 王天真. RNA结合蛋白LIN28在恶性肿瘤发生发展中的作用和分子机制[J].实用肿瘤学杂志, 2019, 33:456-460.]
[39] Feng HQ. Expression of RNA-binding protein LIN28 in primordial germ cell develop of male embryo[D]. Zhengzhou:Zhengzhou University, 2014.[冯涵琪. RNA结合蛋白LIN28在男胎原始生殖细胞中的表达[D]. 郑州:郑州大学, 2014.]
[40] Gell JJ, Zhao J, Chen D, Hunt TJ, Clark AT. PRDM14 is expressed in germ cell tumors with constitutive overexpression altering human germline differentiation and proliferation[J]. Stem Cell Res, 2018, 27:46-56.
[41] Wang XC, Qu GF, Xu YJ. Advances in expression of Podoplanin in malignant tumors[J]. Zhongguo Yi Yao Dao Bao, 2016, 13:41-44.[王新成, 曲国蕃, 徐永军. Podoplanin在恶性肿瘤中表达的研究进展[J]. 中国医药导报, 2016, 13:41-44.]
[42] Mishima K, Kato Y, Kaneko MK, Nakazawa Y, Kunita A, Fujita N, Tsuruo T, Nishikawa R, Hirose T, Matsutani M. Podoplanin expression in primary central nervous system germ cell tumors:a useful histological marker for the diagnosis of germinoma[J]. Acta Neuropathol, 2006, 111:563-568.
[43] Sakurada K, Saino M, Mouri W, Sato A, Kitanaka C, Kayama T. Nestin expression in central nervous system germ cell tumors[J]. Neurosurg Rev, 2008, 31:173-176.
[44] Hu M, Guan H, Lau CC, Terashima K, Jin Z, Cui L, Wang Y, Li G, Yao Y, Guo Y, Li YM, Zhong D, Xiao J, Wan X, Lian X, Feng F, Ren H, Zhao Y, Cheng X, Gu F. An update on the clinical diagnostic value of beta-hCG and alphaFP for intracranial germ cell tumors[J]. Eur J Med Res, 2016, 21:10.
[45] Legault G, Allen JC. Potential role of ventricular tumor markers in CNS germ cell tumors[J]. Pediatr Blood Cancer, 2013, 60:1647-1650.
[46] Kim A, Ji L, Balmaceda C, Diez B, Kellie SJ, Dunkel IJ, Gardner SL, Sposto R, Finlay JL. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors[J]. Pediatr Blood Cancer, 2008, 51:768-773.
[47] Martinez S, Khakoo Y, Gilheeney S, Kramer K, Wolden S, Souweidane M, Dunkel IJ. Marker (+) CNS germ cell tumors in remission:are surveillance MRI scans necessary[J]? Pediatr Blood Cancer, 2014, 61:853-854.
[48] Fujimaki T, Mishima K, Asai A, Tabuchi K, Kobayashi M, Suzuki I, Kirino T. Levels of beta-human chorionic gonadotropin in cerebrospinal fluid of patients with malignant germ cell tumor can be used to detect early recurrence and monitor the response to treatment[J]. Jpn J Clin Oncol, 2000, 30:291-294.
[49] Arita N, Ushio Y, Hayakawa T, Uozumi T, Watanabe M, Mori T, Mogami H. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors[J]. Oncodev Biol Med, 1980, 1(4/5):235-240.
[50] Sugiyama K, Arita K, Tominaga A, Hanaya R, Taniguchi E, Okamura T, Itoh Y, Yamasaki F, Kurisu K. Morphologic features of human chorionic gonadotropin-or alpha-fetoprotein-producing germ cell tumors of the central nervous system:histological heterogeneity and surgical meaning[J]. Brain Tumor Pathol, 2001, 18:115-122.
[51] Seregni E, Massimino M, Nerini Molteni S, Pallotti F, van der Hiel B, Cefalo G, Spreafico F, Fossati F, Bombardieri E. Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors[J]. Int J Biol Markers, 2002, 17:112-118.
[52] Kawaguchi T, Kumabe T, Kanamori M, Saito R, Yamashita Y, Sonoda Y, Watanabe M, Tominaga T. Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors[J]. J Neurooncol, 2011, 104:779-787.
[53] Sasagawa Y, Tachibana O, Nakagawa A, Nakada S, Nojima T, Koya D, Iizuka H. Rapid enlargement of an intracranial germ cell tumor after gonadotropin hormone therapy[J]. J Clin Neurosci, 2016, 31:185-188.
[54] Takami H, Fukushima S, Fukuoka K, Suzuki T, Yanagisawa T, Matsushita Y, Nakamura T, Arita H, Mukasa A, Saito N, Kanamori M, Kumabe T, Tominaga T, Kobayashi K, Nagane M, Iuchi T, Tamura K, Maehara T, Sugiyama K, Nakada M, Kanemura Y, Nonaka M, Yokogami K, Takeshima H, Narita Y, Shibui S, Nakazato Y, Nishikawa R, Ichimura K, Matsutani M. Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors[J]. J Neurooncol, 2015, 124:23-32.
[55] Bourdillon P, Frappaz D, Vasiljevic A, Jouanneau E. Human chorionic gonadotropin elevation is not an intracranial germ cell tumor signature[J]. Acta Neurochir (Wien), 2013, 155:1037-1038.
[56] Wong JM, Chi SN, Marcus KJ, Levine BS, Ullrich NJ, MacDonald S, Lechpammer M, Goumnerova LC. Germinoma with malignant transformation to nongerminomatous germ cell tumor[J]. J Neurosurg Pediatr, 2010, 6:295-298.
[57] Aihara Y, Watanabe S, Amano K, Komatsu K, Chiba K, Imanaka K, Hori T, Ohba T, Dairoku H, Okada Y, Kubo O, Kawamata T. Placental alkaline phosphatase levels in cerebrospinal fluid can have a decisive role in the differential diagnosis of intracranial germ cell tumors[J]. J Neurosurg, 2018, 131:687-694.
[58] Dai K, Luo L, Yue SL, Sun SQ. Immunohistochemical study of intracranial germ cell tumors[J]. Zhonghua Shen Jing Wai Ke Za Zhi, 1998, 14:31-34.[戴珂, 罗麟, 岳盛琳, 孙淑清. 颅内生殖细胞肿瘤的免疫组织化学研究[J]. 中华神经外科杂志, 1998, 14:31-34.]
[59] Kim JY, Park J. Understanding the treatment strategies of intracranial germ cell tumors:focusing on radiotherapy[J]. J Korean Neurosurg Soc, 2015, 57:315-322.
[60] Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ, Coleman N; Children's Cancer and Leukaemia Group. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets[J]. Cancer Res, 2010, 70:2911-2923.
[61] Hsieh TH, Liu YR, Chang TY, Liang ML, Chen HH, Wang HW, Yen Y, Wong TT. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors[J]. Neuro Oncol, 2018, 20:519-530.
[62] Grenabo L, Wang Y, Bratell S, Dahlstrand C, Haraldsson G, Hedelin H, Henriksson C, Wikholm G, Pettersson S, Zachrisson BF. Cytologic diagnosis of primary pineal germ cell tumor with a yolk sac component, in cerebrospinal fluid[J]. Cytopathology, 2019, 138:25-29.